SUV39H1 ỨC CHẾ SỰ BIỂU HIỆN CỦA CÁC GEN HIỆU GIAO TẾ BÀO TỬ ĐỂ THÚC ĐẨY SỰ TRỐN TRÁNH MIỄN DỊCH CỦA KHỐI U KẾT TRÀNG

Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139

Galon, 2007, The adaptive immunologic microenvironment in colorectal cancer: a novel perspective, Cancer Res, 67, 1883, 10.1158/0008-5472.CAN-06-4806

Pages, 2005, Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med, 353, 2654, 10.1056/NEJMoa051424

Camus, 2009, Coordination of intratumoral immune reaction and human colorectal cancer recurrence, Cancer Res, 69, 2685, 10.1158/0008-5472.CAN-08-2654

Kroemer, 2015, Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?, Oncoimmunology, 4, e1058597, 10.1080/2162402X.2015.1058597

Fridman, 2011, Prognostic and predictive impact of intra- and peritumoral immune infiltrates, Cancer Res, 71, 5601, 10.1158/0008-5472.CAN-11-1316

Tosolini, 2011, Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer, Cancer Res, 71, 1263, 10.1158/0008-5472.CAN-10-2907

Mlecnik, 2018, Comprehensive intrametastatic immune quantification and major impact of immunoscore on survival, J Natl Cancer Inst, 110, 97, 10.1093/jnci/djx123

Llosa, 2015, The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints, Cancer Discov, 5, 43, 10.1158/2159-8290.CD-14-0863

Le, 2015, PD-1 blockade in tumors with mismatch-repair deficiency, N Engl J Med, 372, 2509, 10.1056/NEJMoa1500596

Le, 2017, A blueprint to advance colorectal cancer immunotherapies, Cancer Immunol Res, 5, 942, 10.1158/2326-6066.CIR-17-0375

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Moller, 1994, Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium, Int J Cancer, 57, 371, 10.1002/ijc.2910570314

von Reyher, 1998, Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis, Cancer Res, 58, 526

Strater, 2005, Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease, Gut, 54, 661, 10.1136/gut.2004.052696

Masugi, 2017, Tumour CD274 (PD-L1) expression and T cells in colorectal cancer, Gut, 66, 1463, 10.1136/gutjnl-2016-311421

Marisa, 2018, The balance between cytotoxic T-cell lymphocytes and immune checkpoint expression in the prognosis of colon tumors, J Natl Cancer Inst, 110, 68, 10.1093/jnci/djx136

Hodge, 1999, Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines, Cancer Res, 59, 5106

Carter, 1987, Studies on the synthesis of the antitumor agent CC-1065. Synthesis of PDE I and PDE II, inhibitors of cyclic adenosine-3′,5′-monophosphate phosphodiesterase using the 3,3′-bipyrrole strategy, J Ameri Chem Soc, 109, 2711, 10.1021/ja00243a026

O'Boyle, 2011, Open Babel: an open chemical toolbox, J Cheminform, 3, 33, 10.1186/1758-2946-3-33

Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J Comput Chem, 31, 455, 10.1002/jcc.21334

Wang, 2012, Crystal structure of the human SUV39H1 chromodomain and its recognition of histone H3K9me2/3, PLoS One, 7, e52977, 10.1371/journal.pone.0052977

Lu, 2018, Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells, BMC Cancer, 18, 149, 10.1186/s12885-018-4061-y

Pace, 2018, The epigenetic control of stemness in CD8(+) T cell fate commitment, Science, 359, 177, 10.1126/science.aah6499

Rea, 2000, Regulation of chromatin structure by site-specific histone H3 methyltransferases, Nature, 406, 593, 10.1038/35020506

Rice, 2003, Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains, Mol Cell, 12, 1591, 10.1016/S1097-2765(03)00479-9

Fodor, 2010, Mammalian Su(var) genes in chromatin control, Annu Rev Cell Dev Biol, 26, 471, 10.1146/annurev.cellbio.042308.113225

Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122

Kagi, 1994, Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity, Science, 265, 528, 10.1126/science.7518614

Afshar-Sterle, 2014, Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas, Nat Med, 20, 283, 10.1038/nm.3442

LA, 2009, Membrane-bound Fas ligand only is essential for Fas-induced apoptosis, Nature, 461, 659, 10.1038/nature08402

Juneja, 2017, PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity, J Exp Med, 214, 895, 10.1084/jem.20160801

Quintana, 2012, Aiolos promotes TH17 differentiation by directly silencing Il2 expression, Nat Immunol, 13, 770, 10.1038/ni.2363

Allan, 2012, An epigenetic silencing pathway controlling T helper 2 cell lineage commitment, Nature, 487, 249, 10.1038/nature11173

Muller, 2016, A two-state activation mechanism controls the histone methyltransferase Suv39h1, Nat Chem Biol, 12, 188, 10.1038/nchembio.2008

Olcina, 2016, H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK, Oncogene, 35, 793, 10.1038/onc.2015.134

Paschall, 2015, H3K9 trimethylation silences Fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance, J Immunol, 195, 1868, 10.4049/jimmunol.1402243

Nizialek, 2016, Cancer-predisposition gene KLLN maintains pericentric H3K9 trimethylation protecting genomic stability, Nucleic Acids Res, 44, 3586, 10.1093/nar/gkv1481

Suryo Rahmanto, 2016, Inactivating ARID1A tumor suppressor enhances TERT transcription and maintains telomere length in cancer cells, J Biol Chem, 291, 9690, 10.1074/jbc.M115.707612

Feng, 2017, Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase, Cancer Res, 77, 401, 10.1158/0008-5472.CAN-16-1567

Greiner, 2005, Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9, Nat Chem Biol, 1, 143, 10.1038/nchembio721

Russ, 2014, Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation, Immunity, 41, 853, 10.1016/j.immuni.2014.11.001

Ries, 2014, Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, Cancer Cell, 25, 846, 10.1016/j.ccr.2014.05.016

Holmgaard, 2016, Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy, Oncoimmunology, 5, e1151595, 10.1080/2162402X.2016.1151595

Gabrilovich, 2012, Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, 12, 253, 10.1038/nri3175

Hanson, 2000, Eradication of established tumors by CD8+ T cell adoptive immunotherapy, Immunity, 13, 265, 10.1016/S1074-7613(00)00026-1

Russell, 2002, Lymphocyte-mediated cytotoxicity, Annu Rev Immunol, 20, 323, 10.1146/annurev.immunol.20.100201.131730

Strater, 1997, CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis, Gastroenterology, 113, 160, 10.1016/S0016-5085(97)70091-X

Strater, 1995, In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis, Gut, 37, 819, 10.1136/gut.37.6.819